| |
VKA, n = 138 (45 %)
|
Dabigatran, n = 68 (22 %)
|
Rivaroxaban, n = 100 (33 %)
|
p value for difference between VKA and Dabigatran
|
p value for difference between VKA and Rivaroxaban
|
pvalue for difference between dabigatran and rivaroxaban
|
|---|
|
LA/LAA thrombus
|
5 (4 %)
|
0 (0 %)
|
2 (2 %)
|
0.173
|
0.515
|
0.702
|
|
Dense SEC
|
2 (1 %)
|
1 (1 %)
|
2 (2 %)
|
1
|
1
|
1
|
|
LAAV <20 cm/s
|
5 (4 %)
|
1 (1 %)
|
1 (1 %)
|
0.666
|
1
|
0.405
|
|
LA abnormality
|
12 (9 %)
|
2 (3 %)
|
5 (5 %)
|
0.15
|
0.702
|
0.318
|
-
LA left atrium, LAA left atrial appendage, LAAV left atrial appendage velocity, SEC spontaneous echo contrast, VKA vitamin K antagonists
